National Research Corporation (NRC) will suspend its quarterly dividend in 2020 because of the COVID-19 pandemic. Last year the company hiked its quarterly dividend by 10.5 percent to $0.21 per share.

In a form 8-K filing dated May 18, 2020, the suspension is announced and explained by the company: The Company’s Board of Directors determined not to declare a dividend on the Company’s common stock in the second quarter of 2020.  Thedetermination was made in light of the general economic uncertainty created by the COVID-19 pandemic and the Company’s desire to maintain a conservative liquiditycushion.  No determination has been made at this time regarding the declaration of future dividends.

National Research Corporation provides analytics to healthcare providers. The company's portfolio of subscription-based solutions provides information and analysis to healthcare organizations and payers across a range of constituent-related elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions and physician engagement.